Ravichandran K, Hamdan Nasser Al, Dyab Abdul Rahman Al
BESC Department, King Faisal Specialist Hospital and Research Centre, P.O.Box 3354, MBC 03 Riyadh 11211 Saudi Arabia.
Asian Pac J Cancer Prev. 2005 Jan-Mar;6(1):72-6.
Breast cancer is the most frequent tumor among Saudi women, accounting to 19.8% of female cancers. The present study was conducted to determine 5-year survival for all cases of invasive breast cancer that occurred during 1994-96 in the province of Riyadh (n=316). The overall observed survival probability of the study population at 1, 3 and 5 years was 93.9%, 79.2% and 59.6%, respectively. The 5 year survivals for the younger (< 40 years), older (50 + years) and 40-49 years patients were 60.6%, 51.6% and 69.2% respectively, the differences not reaching statistical significance. While there was not a great deal of variation in the 5-year survival between cases with regional (55.6%), distant metastasis (57.6%) and extent of disease unknown (56.7%) cases, localized (67.5%) cases had a clearly better prognosis. An increased but not significant hazard was seen for the cases with regional and distant metastasis disease, 1.40 and 1.11 respectively, compared to localized cases. The 5-year survival for duct carcinomas (62.8%) was greater than for adenocarcinomas (55.6%) and lobular carcinomas (50.0%).
乳腺癌是沙特女性中最常见的肿瘤,占女性癌症的19.8%。本研究旨在确定1994 - 1996年期间利雅得省发生的所有浸润性乳腺癌病例(n = 316)的5年生存率。研究人群在1年、3年和5年时的总体观察生存率分别为93.9%、79.2%和59.6%。年龄较轻(<40岁)、年龄较大(50岁及以上)和40 - 49岁患者的5年生存率分别为60.6%、51.6%和69.2%,差异未达到统计学显著性。区域转移(55.6%)、远处转移(57.6%)和疾病范围未知(56.7%)的病例与局部病变(67.5%)的病例相比,5年生存率虽无很大差异,但局部病变病例的预后明显更好。与局部病变病例相比,区域转移和远处转移疾病的病例风险增加但不显著,分别为1.40和1.11。导管癌的5年生存率(62.8%)高于腺癌(55.6%)和小叶癌(50.0%)。